ArticleScientific reports2018

Circulating Fibroblast Growth Factor-23 Levels are Associated with an Increased Risk of Anemia Development in Patients with Nondialysis Chronic Kidney Disease.

Ki Heon Nam et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.